181 related articles for article (PubMed ID: 37598013)
1. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature.
Javed AA; Zhu Z; Kinny-Köster B; Habib JR; Kawamoto S; Hruban RH; Fishman EK; Wolfgang CL; He J; Chu LC
Diagn Interv Imaging; 2024 Jan; 105(1):33-39. PubMed ID: 37598013
[TBL] [Abstract][Full Text] [Related]
2. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
[TBL] [Abstract][Full Text] [Related]
3. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
[TBL] [Abstract][Full Text] [Related]
4. CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor.
Zhao Z; Bian Y; Jiang H; Fang X; Li J; Cao K; Ma C; Wang L; Zheng J; Yue X; Zhang H; Wang X; Madabhushi A; Xu J; Jin G; Lu J
Acad Radiol; 2020 Dec; 27(12):e272-e281. PubMed ID: 32037260
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
[TBL] [Abstract][Full Text] [Related]
6. A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors.
Ye JY; Fang P; Peng ZP; Huang XT; Xie JZ; Yin XY
Eur Radiol; 2024 Mar; 34(3):1994-2005. PubMed ID: 37658884
[TBL] [Abstract][Full Text] [Related]
7. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
[TBL] [Abstract][Full Text] [Related]
8. CT-Based Radiomics Score for Distinguishing Between Grade 1 and Grade 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
Bian Y; Jiang H; Ma C; Wang L; Zheng J; Jin G; Lu J
AJR Am J Roentgenol; 2020 Oct; 215(4):852-863. PubMed ID: 32755201
[No Abstract] [Full Text] [Related]
9. Preoperative prediction of pancreatic neuroendocrine tumor grade based on
Ma J; Wang X; Tang M; Zhang C
Endocrine; 2024 Feb; 83(2):502-510. PubMed ID: 37715934
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging.
Liu C; Bian Y; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Lu J; Xu J; Shao C
Acad Radiol; 2022 Apr; 29(4):e49-e60. PubMed ID: 34175209
[TBL] [Abstract][Full Text] [Related]
11. A preoperative computed tomography radiomics model to predict disease-free survival in patients with pancreatic neuroendocrine tumors.
Homps M; Soyer P; Coriat R; Dermine S; Pellat A; Fuks D; Marchese U; Terris B; Groussin L; Dohan A; Barat M
Eur J Endocrinol; 2023 Oct; 189(4):476-484. PubMed ID: 37787635
[TBL] [Abstract][Full Text] [Related]
12. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
[TBL] [Abstract][Full Text] [Related]
13. Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.
Bian Y; Zhao Z; Jiang H; Fang X; Li J; Cao K; Ma C; Guo S; Wang L; Jin G; Lu J; Xu J
J Magn Reson Imaging; 2020 Oct; 52(4):1124-1136. PubMed ID: 32343872
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
[TBL] [Abstract][Full Text] [Related]
15. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features.
Mori M; Palumbo D; Muffatti F; Partelli S; Mushtaq J; Andreasi V; Prato F; Ubeira MG; Palazzo G; Falconi M; Fiorino C; De Cobelli F
Eur Radiol; 2023 Jun; 33(6):4412-4421. PubMed ID: 36547673
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.
Chiti G; Grazzini G; Flammia F; Matteuzzi B; Tortoli P; Bettarini S; Pasqualini E; Granata V; Busoni S; Messserini L; Pradella S; Massi D; Miele V
Radiol Med; 2022 Sep; 127(9):928-938. PubMed ID: 35917099
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs.
Bian Y; Li J; Cao K; Fang X; Jiang H; Ma C; Jin G; Lu J; Wang L
Abdom Radiol (NY); 2021 Feb; 46(2):667-680. PubMed ID: 32808056
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
